This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biomea Fusion, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Junlu Ding: Innovator in Pharmaceutical Chemistry
Introduction
Junlu Ding is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry. His innovative work has led to the development of a unique compound that holds promise for various applications.
Latest Patents
Junlu Ding holds a patent for a compound described as N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(R)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide. This compound, referred to as Compound A, showcases his expertise in creating crystalline forms that may have therapeutic benefits. He has 1 patent to his name.
Career Highlights
Ding is currently employed at Biomea Fusion, Inc., where he continues to push the boundaries of innovation in drug development. His work is characterized by a commitment to advancing pharmaceutical solutions that can improve patient outcomes.
Collaborations
Some of his notable coworkers include Satish Goud Puppali and James T Palmer. Their collaborative efforts contribute to the dynamic research environment at Biomea Fusion, Inc.
Conclusion
Junlu Ding's contributions to pharmaceutical chemistry exemplify the spirit of innovation. His work not only enhances the field but also holds potential for significant advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile